Atrial Fibrillation (Thromboembolic Risk)
The most prevalent supraventricular cardiac arrhythmia, predisposing patients to intra-atrial thrombus formation, cardiogenic thromboembolism, and ischemic stroke.
Epidemiology & Prevalence:
Projected to affect over 12 million individuals in the US by 2030; confers a 5-fold increase in ischemic stroke risk.
Clinical Screening Guidelines
2020 ESC and 2023 ACC/AHA Atrial Fibrillation Guidelines mandate using the CHA₂DS₂-VASc risk score to determine the necessity of oral anticoagulation.
Recommended Screening Tools & Calculators (1)
Clinical Disclaimer & Scope of Use
This instrument is designed for educational, informational, and clinical reference purposes. Screening scores do not constitute a definitive medical diagnosis. Individual clinical management must integrate full diagnostic history, physical examination, and laboratory data by a licensed healthcare professional.
Read our full Medical Disclaimer and Privacy Policy.